ZA975197B - Intermediates for oligonucleotides. - Google Patents
Intermediates for oligonucleotides.Info
- Publication number
- ZA975197B ZA975197B ZA9705197A ZA975197A ZA975197B ZA 975197 B ZA975197 B ZA 975197B ZA 9705197 A ZA9705197 A ZA 9705197A ZA 975197 A ZA975197 A ZA 975197A ZA 975197 B ZA975197 B ZA 975197B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- hydrogen
- formula
- nucleoside
- nuc
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 239000002777 nucleoside Substances 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9612600.8A GB9612600D0 (en) | 1996-06-13 | 1996-06-13 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA975197B true ZA975197B (en) | 1997-12-15 |
Family
ID=10795396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9705197A ZA975197B (en) | 1996-06-13 | 1997-06-12 | Intermediates for oligonucleotides. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6329519B1 (de) |
| EP (1) | EP0906327B1 (de) |
| JP (1) | JP2000512288A (de) |
| CN (1) | CN1221423A (de) |
| AT (1) | ATE210675T1 (de) |
| AU (1) | AU2971997A (de) |
| BR (1) | BR9709791A (de) |
| CA (1) | CA2257453A1 (de) |
| DE (1) | DE69709098T2 (de) |
| GB (1) | GB9612600D0 (de) |
| WO (1) | WO1997047636A2 (de) |
| ZA (1) | ZA975197B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3756313B2 (ja) * | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| USRE44779E1 (en) | 1997-03-07 | 2014-02-25 | Santaris Pharma A/S | Bicyclonucleoside and oligonucleotide analogues |
| US6770748B2 (en) | 1997-03-07 | 2004-08-03 | Takeshi Imanishi | Bicyclonucleoside and oligonucleotide analogue |
| US7030230B2 (en) | 2002-10-25 | 2006-04-18 | Isis Pharmaceuticals, Inc. | Process of purifying phosphoramidites |
| EP1692139B1 (de) | 2003-11-13 | 2013-02-13 | Isis Pharmaceuticals, Inc. | 5,6-dihydroxy-isoindolderivate als linker für die festphasensynthese von oligomeren |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3307744A1 (de) | 1983-03-04 | 1984-09-06 | Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig | 2'-desoxy-3'-phosphonylmethyl-nucleoside |
| EP0406309A4 (en) * | 1988-03-25 | 1992-08-19 | The University Of Virginia Alumni Patents Foundation | Oligonucleotide n-alkylphosphoramidates |
| DE4037363A1 (de) | 1990-04-09 | 1991-10-10 | Europ Lab Molekularbiolog | 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten |
| US5658731A (en) * | 1990-04-09 | 1997-08-19 | Europaisches Laboratorium Fur Molekularbiologie | 2'-O-alkylnucleotides as well as polymers which contain such nucleotides |
| US5378825A (en) | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
| US5386023A (en) * | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
| GB9304618D0 (en) | 1993-03-06 | 1993-04-21 | Ciba Geigy Ag | Chemical compounds |
| GB9311682D0 (en) | 1993-06-05 | 1993-07-21 | Ciba Geigy Ag | Chemical compounds |
| GB9417746D0 (en) | 1994-09-03 | 1994-10-19 | Ciba Geigy Ag | Chemical compounds |
-
1996
- 1996-06-13 GB GBGB9612600.8A patent/GB9612600D0/en active Pending
-
1997
- 1997-06-03 CA CA002257453A patent/CA2257453A1/en not_active Abandoned
- 1997-06-03 AT AT97924155T patent/ATE210675T1/de active
- 1997-06-03 AU AU29719/97A patent/AU2971997A/en not_active Abandoned
- 1997-06-03 DE DE69709098T patent/DE69709098T2/de not_active Expired - Lifetime
- 1997-06-03 WO PCT/GB1997/001490 patent/WO1997047636A2/en active IP Right Grant
- 1997-06-03 JP JP10501337A patent/JP2000512288A/ja active Pending
- 1997-06-03 CN CN97195452A patent/CN1221423A/zh active Pending
- 1997-06-03 US US09/202,294 patent/US6329519B1/en not_active Expired - Lifetime
- 1997-06-03 BR BR9709791A patent/BR9709791A/pt not_active Application Discontinuation
- 1997-06-03 EP EP97924155A patent/EP0906327B1/de not_active Expired - Lifetime
- 1997-06-12 ZA ZA9705197A patent/ZA975197B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9612600D0 (en) | 1996-08-21 |
| ATE210675T1 (de) | 2001-12-15 |
| EP0906327B1 (de) | 2001-12-12 |
| AU2971997A (en) | 1998-01-07 |
| WO1997047636A2 (en) | 1997-12-18 |
| US6329519B1 (en) | 2001-12-11 |
| WO1997047636A3 (en) | 1998-02-12 |
| CN1221423A (zh) | 1999-06-30 |
| EP0906327A2 (de) | 1999-04-07 |
| CA2257453A1 (en) | 1997-12-18 |
| DE69709098D1 (de) | 2002-01-24 |
| DE69709098T2 (de) | 2002-09-05 |
| JP2000512288A (ja) | 2000-09-19 |
| BR9709791A (pt) | 1999-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117848A0 (en) | Novel compounds a process for their production and pharmacetical compositions containing same | |
| PT915866E (pt) | Processo aperfeicoado para a sintese de esteres protegidos do acido (s)-3,4-di-hidroxibutirico | |
| ATE188216T1 (de) | Therapeutische mittel für die parkinsonsche krankheit | |
| GB2346879A (en) | Preparation of 3-substituted adenines and imidazo pyridines | |
| DE69823648D1 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
| HUP9902576A1 (hu) | Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben | |
| MX9602806A (es) | Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales. | |
| GR3021557T3 (en) | Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates | |
| ZA975197B (en) | Intermediates for oligonucleotides. | |
| YU12000A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
| ES8802499A1 (es) | Procedimiento para la obtencion de 1-aril-4-nitropirazoles | |
| SE8501988D0 (sv) | Iminothiazolidine derivatives | |
| IL104478A (en) | N-5-protected 2,5-diamino-4, 6-dichloropyrimidines and processes for their preparation | |
| HK1019063A1 (en) | Dibenzo-oxazepine and- dioxepine derivatives and their use as anti-tumor agents | |
| GB9906328D0 (en) | 2-Substituted RNA preparation | |
| YU71400A (sh) | Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana | |
| ID19038A (id) | Turunan feniletanolaminotetralinkarboksamida | |
| DE69711506D1 (de) | Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung | |
| TH22634A (th) | " เบนซอกซาโซลิล และเบนโซไธอะโซลิลออกซาโซลิดิโนน " | |
| MX9708083A (es) | Inmunopotenciacion con inosina monofostato resistente a la 5'-nucleotidasa derivados y sus usos. | |
| DE69816095D1 (de) | Herstellung von beta-mehtylcarbapenem-zwischenprodukten | |
| YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE | |
| ATE315575T1 (de) | Immunopotenzierende 5'-nucleotidase-resistente inosinmonophosphat-derivate und ihre verwendung |